Enrique Morell-Bernal

Murcia, MU, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Effect of Non-nucleoside Resistance-Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights From the Real-World RELATIVITY Cohort.

Effect of Non-nucleoside Resistance-Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights From the Real-World RELATIVITY Cohort.

Journal: Open forum infectious diseases

Published: June 10, 2026

Elevated Plasma GDF-15 Levels are Associated with the Immune Non-Responder Phenotype in People with HIV.

Elevated Plasma GDF-15 Levels are Associated with the Immune Non-Responder Phenotype in People with HIV.

Journal: Infectious diseases and therapy

Published: May 29, 2026

Rethinking HIV resistance in the era of long-acting therapy: from isolated events to durable exposure.

Rethinking HIV resistance in the era of long-acting therapy: from isolated events to durable exposure.

Journal: AIDS (London, England)

Published: May 20, 2026

Artificial intelligence in HIV research: a structured review and task-oriented clinical framework.

Artificial intelligence in HIV research: a structured review and task-oriented clinical framework.

Journal: Frontiers in digital health

Published: April 23, 2026

Phase IIB, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intravenous Defibrotide for the Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome in COVID-19.

Phase IIB, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intravenous Defibrotide for the Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome in COVID-19.

Journal: European journal of haematology

Published: February 26, 2026

Associations Between Nasal Receptors and Olfactory Dysfunction and Dysgeusia in Coronavirus Disease 2019 (COVID-19).

Associations Between Nasal Receptors and Olfactory Dysfunction and Dysgeusia in Coronavirus Disease 2019 (COVID-19).

Journal: Journal of clinical medicine

Published: January 13, 2026

Persistence of late HIV diagnosis and poorer response to antiretrovirals: a comparison between migrants and native-born people with HIV in Spain.

Persistence of late HIV diagnosis and poorer response to antiretrovirals: a comparison between migrants and native-born people with HIV in Spain.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: November 17, 2025

Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort.

Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort.

Journal: Journal of the International AIDS Society

Published: October 11, 2025

A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study).

A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study).

Journal: The Journal of antimicrobial chemotherapy

Published: July 17, 2025

Rare case of extralymphatic dirofilariasis presenting as a facial subcutaneous nodule in non-endemic region of Spain.

Rare case of extralymphatic dirofilariasis presenting as a facial subcutaneous nodule in non-endemic region of Spain.

Journal: IDCases

Published: July 13, 2025

Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort.

Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort.

Journal: AIDS (London, England)

Published: July 02, 2025

Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort.

Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort.

Journal: AIDS (London, England)

Published: July 02, 2025

Showing 1-12 of 39

Last Updated: 09/26/2026